Coffee consumption has been correlated with a decreased risk of developing Alzheimer’s disease (AD) and Parkinson’s disease (PD). A new study is the first to show that a compound found in brewed coffee may elicit neuroprotective effects by inhibiting the aggregation of amyloid-beta and tau.

Coffee consumption has been correlated with a decreased risk of developing Alzheimer’s disease (AD) and Parkinson’s disease (PD). A new study is the first to show that a compound found in brewed coffee may elicit neuroprotective effects by inhibiting the aggregation of amyloid-beta and tau.: https://ift.tt/2qxYVmR Read more... https://ift.tt/2PKajdt